Le Lézard
Classified in: Health
Subject: PLW

KATOR Granted Third US Patent for Innovative Suture Anchor Technology


LOGAN, Utah, Dec. 4, 2018 /PRNewswire/ -- KATOR, a start-up medical device company focused on advanced tissue-to-bone reattachment systems, announced today that the United States Patent and Trademark Office has recently granted the company a key patent related to its innovative suture anchor technology.

US Patent 10,136,883 entitled "Method of Anchoring a Suture" is the third patent to issue from the intellectual property portfolio held by the company that includes additional pending US and international patent applications.  The patent covers the novel combination of a knotless suture anchor used in combination with a transosseous suture method.  This platform technology enables much stronger surgical repair constructs than currently marketed suture anchors, enabling surgeons to achieve stronger tissue-to-bone repairs with fewer suture anchors. In a recent publication in a leading peer review medical journal, biomechanical testing demonstrated the superior performance of the 2 anchor, knotless, transosseous repair from KATOR to a 4 anchor, transosseous equivalent repair.1   

KATOR is a medical device company incubated and operated by Surgical Frontiers.

1. Tashjian, RZ, et al., "Biomechanical Comparison of Transosseous Knotless Rotator Cuff Repair Versus Transosseous Equivalent Repair: Half The Anchors With Equivalent Biomechanics?" Arthroscopy, 2018 Jan;34(1):58-63.

About Surgical Frontiers

Surgical Frontiers develops advanced surgical technologies that are ready for clinical use.   Focused primarily on musculoskeletal injuries and pathologies, the company collaborates with surgeons, industry, universities, and investors to bring advanced surgical technologies to the market that improve healthcare.  

Contacts:

Mr. Wade Fallin
Chief Executive Officer
[email protected] 
http://surgicalfrontiers.com/kator/ 
800-230-3710

SOURCE KATOR, LLC


These press releases may also interest you

at 00:05
ImmunityBio, Inc. , an immunotherapy company, today announced positive overall survival results in the QUILT 3.055 study of 2nd- and 3rd-line NSCLC patients who progressed after checkpoint inhibitor therapy (pembrolizumab, nivolumab, or atezolizumab)...

at 00:05
The Insurance Institute for Highway Safety is updating its vehicle-to-vehicle front crash prevention test to address crashes that occur at higher speeds and those in which the struck vehicle is a motorcycle or large truck. Only one of the first 10...

at 00:00
Nutriessential.com recently announced its expansion into Oceania, Asia, and the Gulf. The company has been providing science-backed GMP-certified supplements in the US, Europe and Canada since 2005 and decided to expand owing to rising global demands...

24 avr 2024
Summit Clinical Research LLC ("Summit") is deeply saddened by the death of Co-Founder and Chairman Dr. Stephen Harrison. Summit mourns Dr. Harrison and extends its heartfelt condolences to his family and loved ones.   During an illustrious 30-year...

24 avr 2024
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...

24 avr 2024
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...



News published on and distributed by: